FDA — authorised 2 April 1974
- Marketing authorisation holder: PURDUE FREDERICK
- Status: approved
🇺🇸 Sulfabid in United States
FDA authorised Sulfabid on 2 April 1974
Marketing authorisations
FDA — authorised 2 April 1974
- Application: NDA013092
- Marketing authorisation holder: PURDUE FREDERICK
- Local brand name: SULFABID
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 7 October 1977
- Application: NDA013093
- Marketing authorisation holder: PHARM RES ASSOC
- Local brand name: SULFABID
- Indication: SUSPENSION — ORAL
- Status: approved
Sulfabid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Sulfabid approved in United States?
Yes. FDA authorised it on 2 April 1974; FDA authorised it on 2 April 1974; FDA authorised it on 7 October 1977.
Who is the marketing authorisation holder for Sulfabid in United States?
PURDUE FREDERICK holds the US marketing authorisation.